Vividion Therapeutics | ApexOnco - Clinical Trials news and analysis

x

“I am very impressed - it has become my go-to platform”

Chief Business Officer

US public biotech company

Click here for more information

Trial results

1 February 2024

Roche perseveres with FAP

A third discontinuation leaves one anti-FAP project in Roche’s clinical pipeline.

Trial results

18 September 2023

Bayer looks to clinical validation for $1.5bn Vividion deal

Subscribe to Vividion Therapeutics